Related Experiment Video
Updated: May 9, 2026
06:21
Hepatic Glucose Production, Ureagenesis, and Lipolysis Quantified using the Perfused Mouse Liver Model
Published on: October 6, 2023
[Liver disorders in diabetic patients].
1IV. interní klinika 1. lékařské fakulty UK a VFVN Praha. bruha@cesnet.cz
Vnitrni Lekarstvi
|August 6, 2013
Summary
Diabetes and liver disease are closely linked, with each condition increasing the risk of the other. Managing diabetes and lifestyle is key for liver health, especially for nonalcoholic steatohepatitis.
Area of Science:
- Hepatology
- Endocrinology
- Metabolic Syndrome
Background:
- Diabetes mellitus and liver disorders share a bidirectional relationship, increasing the prevalence and risk of developing each condition.
- Diabetes is a leading cause of chronic liver disease in developed nations, encompassing conditions from simple steatosis to cirrhosis and hepatocellular carcinoma.
- Nonalcoholic fatty liver disease (NAFLD) is a common manifestation of metabolic syndrome, characterized by insulin resistance, obesity, dyslipidemia, and hypertension.
Purpose of the Study:
- To elucidate the complex interplay between diabetes and various liver disorders.
- To highlight the spectrum of liver conditions associated with diabetes, including nonalcoholic steatohepatitis (NASH).
- To discuss the current understanding and management strategies for NAFLD and its progression.
Main Methods:
- Review of existing literature on the relationship between diabetes and liver disease.
- Analysis of the pathological progression of nonalcoholic steatosis to steatohepatitis and fibrosis.
- Examination of the components of metabolic syndrome and their association with liver manifestations.
Main Results:
- Diabetic patients exhibit a higher incidence of liver disorders, while liver disease patients have an increased risk of developing diabetes.
- Nonalcoholic steatohepatitis (NASH) is a significant liver manifestation of metabolic syndrome, linked to insulin resistance and other metabolic abnormalities.
- While steatosis is benign, inflammatory progression to steatohepatitis and fibrosis represents unfavorable liver disorder development.
Conclusions:
- Effective management of diabetes and associated metabolic conditions is crucial for mitigating liver disease progression.
- Lifestyle modifications, including weight reduction and treatment of dyslipidemia, are fundamental in managing nonalcoholic steatohepatitis.
- Current evidence does not support a significant role for "hepatoprotective" agents in the treatment of steatohepatitis.
Related Concept Videos
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...